Publications by authors named "Daniel Rutrick"

Claim this Profile
1
18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies.
Daniel Rutrick, Susan M Learned, Brent Boyett, David Hassman, Sunita Shinde

J Subst Use Addict Treat· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis.
Anne C Andorn, Barbara R Haight, Sunita Shinde, Paul J Fudala, Yue Zhao, Daniel Rutrick

J Clin Psychopharmacol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study.
Daniel Rutrick, Dan J Stein, Ganesan Subramanian, Brian Smith, Maurizio Fava

Adv Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis